LifeStyle

• 
  Medipost's clinical trial approved to evaluate efficacy of knee osteoarthritis treatment SEOUL -- Medipost, a South Korean biotech firm know for stem cell-based treatment, has applied for state approval to go ahead with phase 2 clinical trials to evaluate the safety and efficacy of its next-generation intra-articular Injectable treatment and prevention of knee osteoarthritis, code-named "SMUP-IA-01" Medipost's SMUP-Cell platform technology for developing next-generation cell therapy products enables the selection of small-sized high 2021-07-30
• 
  [INTERVIEW] Pharmaceutical industry wants full government support to enhance international competitiveness SEOUL -- A COVID-19 pandemic has activated the consignment production of vaccines developed by multinational pharmaceutical companies in South Korea, elevating the status of domestic pharmaceutical and bio companies that have exhausted efforts over the past decade to innovate quality and develop new drugs, becoming a crucial industry like automobiles and semiconductors. The domestic pharmaceutical market has seen steady growth, promoting itself as a social 2021-07-28
• 
  American toddler music entertainer loses legal battle against Korean Baby Shark video SEOUL -- Johnny Only, an American toddler music entertainer known for his rendition of "Baby Shark," lost a legal suit against a Korean YouTube video containing the same song that went viral worldwide, after a South Korean court ruled that children's songs handed down by oral tradition are not copyrighted. Only filed a suit seeking damage compensation in March 2019, accusing South Korea's education and entertainment company, SmartS 2021-07-23
• 
  Hyundai Steel works on method to recycle shellfish and oyster shell for furnace SEOUL -- Hyundai Steel, affiliated with South Korea's Hyundai auto group, is in the final phase of introducing a method to recycle shellfish and oyster shells that have been an environmental issue due to a huge accumulation of waste mainly along the southern coast. South Korea is one of Asia's biggest oyster farming countries. Adding limestone in the process of sintering iron ore for furnace injection can improve productivity and reduce fuel costs. Hyundai 2021-07-20
• 
  Researchers use advanced virtual screening to select three candidates for COVID-19 therapy SEOUL -- Through advanced computer-based virtual screening, researchers have selected three candidates for preclinical trials to see if they can be used for the treatment of patients infected with a new coronavirus. The three including omipalisib showed antiviral activity in human lung cells, but additional preclinical tests are required to find their optimal drug concentration and minimize toxicity. For drug repurposing, which is 2021-07-08
• 
  Researchers prove mud flat's ability to capture carbon SEOUL -- Blue carbon is the term for carbon captured by ocean and coastal ecosystems. Seagrasses, mangroves, and salt marshes capture carbon, acting as a carbon sink. Most of the carbon taken up by these coastal ecosystems is stored below ground. Protecting and restoring coastal habitats is a good way to reduce climate change. A research team led by Khim Jong-seong, a professor in Seoul National University's school of earth and e 2021-07-06
• 
  Shin Poong expands clinical study to test malaria drug for COVID-19 treatment SEOUL -- A South Korean pharmaceutical firm specializing in remedy drugs will push ahead with an expanded study to evaluate the effectiveness of Pyramax, a fixed-dose combination medication for the treatment of malaria, although it did not show any statistical significance at second-stage clinical trials as a candidate to treat patients infected with a new coronavirus. Pyramax, produced by Shin Poong Pharm, is on the World Health Organization's list of essentia 2021-07-06
• 
  Disinfection robots with ultraviolet-C germicidal lamps to be deployed at airport SEOUL -- As part of a campaign to stop the spread of COVID-19, autonomous disinfection robots installed with ultraviolet-C "germicidal" lamps will be deployed along the route of travelers from entry gates to quarantine stations at Incheon International Airport, South Korea's main gateway, along with quarantine guide robots. Ultraviolet-C (UV-C) radiation is a known disinfectant for air, water and surfaces that can help mitigate the risk of acquiring 2021-07-05
• 
  S. Korea launches consortium to develop next-generation mRNA vaccine platform SEOUL -- South Korea launched a special government-sponsored consortium to develop a next-generation messenger RNA vaccine platform amid growing public disappointment over the delayed launch of homemade COVID-19 vaccines. The consortium aims to develop a new vaccine capable of preventing infections by coronavirus variants. The K-mRNA consortium, launched in a ceremony hosted by the Ministry of Health Welfare on June 29, involves three drug makers -- Hanmi Pharmaceu 2021-06-29
• 
  ToolGen seals technology transfer deal with Australian partner on gene therapy SEOUL -- ToolGen, a South Korean developer of genome editing technology, has a technology transfer deal with Cartherics Pty, a biotech startup in Australia, for the development of next-generation gene therapy using third-generation genetic scissors to cut out genetic information in cells. The Australian company aims to carry out first-stage clinical trials for ovarian cancer in the United States in 2022. Toolgen said it would receive a certain stake in Carther 2021-06-28
• 
  Genexine develops hybrid technology for COVID-19 vaccine SEOUL -- Genexine, a clinical-stage biotechnology company in South Korea, joined hands with a domestic partner to develop hybrid vaccine technology that complements the shortcomings of DNA and messenger RNA vaccines which are in use worldwide to curb the spread of COVID-19. The novel coronavirus is studded with proteins that it uses to enter human cells. Spike proteins make a tempting target for potential vaccines and treatments. DNA vaccines transfect a spec 2021-06-25
• 
  Clinical trails approved to check efficacy of Korean blackberry for cancer treatment SEOUL -- An Oriental medicine research center in South Korea has won state approval to go ahead with clinical trials to demonstrate the efficacy of KIOM-ICI-1, a drug candidate for immuno-cancer treatment using substances extracted from rubus coreanus, a species of raspberry native to East Asian countries. Rubus coreanus, or known as Korean blackberry, produces edible berries that are fermented into fruit wine which has been taken to prevent problems associated wit 2021-06-23
• 
  Moderna's COVID-19 vaccine wins state approval in S. Korea SEOUL -- South Korean state regulators have approved the use of a COVID-19 vaccine produced by U.S. biotech company Moderna, saying there was no major safety problem as a result of reviewing safety and effectiveness. Moderna has agreed to ship vaccine doses for 20 million people. Moderna became the fourth company to sell COVID-19 vaccines in South Korea after AstraZeneca PLC, Pfizer-BioNTech and Johnson & Johnson, according to the Ministry of Food and Drug Safety. 2021-05-21
• 
  Researchers use electrostatic spray technology to remove viruses and fine dust floating in the air SEOUL -- A state research institute has successfully demonstrated the performance of air purifiers using electrostatic spray technology and high voltage to generate hydrogen peroxide and ozone water that can remove germs and viruses floating in the air. Unlike conventional air purifiers, filters were not used in a method that can dramatically lower maintenance costs. Electrostatic spray technology is a new way to apply clean 2021-05-04
• 
  SK Telecom teams up with major hospital to develop AI video diagnostic assistance solution SEOUL -- A major hospital in South Korea will work with SK Telecom to develop a video diagnostic assistance solution using artificial intelligence that would reduce the burden on medical staff by diagnosing disease conditions more quickly and accurately and allow patients to receive faster treatment. The Catholic Medical Center (CMC) with 6,300 beds in eight hospitals will provide high-quality medical big data and verify the solution to improve completeness 2021-04-30
• 
  Genome information of some 10,000 people decoded in UNIST-led project SEOUL -- A five-year project led by a research institute in the southern city of Ulsan to collect and decrypt genome information of some 10,000 people has been completed for precise genetic disease analysis. The project is aimed at strengthening the competitiveness of South Korea's bio-industry by building decoded genome information as key public data. The project involving hospitals and university research teams began in 2016, led by the Ulsan National Institu 2021-04-26
• 
  Two COVID-19 self-testing kits win conditional approval for domestic use SEOUL -- Two homemade diagnostic kits for self-testing secured conditional government approval for domestic use, marking a major shift in the policy of South Korea's anti-epidemic control center which has maintained a conservative attitude in introducing convenient rapid test kits in its fight against COVID-19. The two devices have already been used abroad. The Ministry of Food and Drug Safety said it has approved two antigen self-testing kits devel 2021-04-23
• 
  5G-based quarantine robot makes commercial debut at university hospital SEOUL -- A 5G-based robot featuring guidance and quarantine functions made its commercial debut at a university hospital by combining a real-time location tracking system and abilities to analyze the density of visitors for social distancing. The robot allows citizens to visit the hospital without any anxiety about COVID-19 infection SK Telecom (SKT) said it has established a quarantine robot solution at Yongin Severance Hospital operated by Yonsei Universi 2021-04-19
• 
  Huons consortium to produce Russian vaccine Sputnik in S. Korea SEOUL -- A consortium led by Huons Global, a pharmaceutical company based in South Korea, has signed a technology transfer contract to produce Sputnik V, a COVID-19 vaccine developed by Russia's state research center. Pilot production is set to begin in August, and the consortium will build facilities capable of producing more than 100 million doses a month. Huons is the second South Korean company to seal a contract with Russia's sovereign wealt 2021-04-16
• 
  Namyang apologizes for causing misunderstanding about Bulgaris' anti-virus effect SEOUL -- Namyang Dairy Products, a major dairy food producer in South Korea, apologized for causing public misunderstanding about the anti-virus effect of its fermented milk brand Bulgaris after a government body called for legal action to punish the company for deceiving consumers with "hyped" publicity. Bulgaris contains complex strains such as lactobacillus, acidophilus and bulgaricus, more than regular fermented milk products. The effect of probiot 2021-04-16